HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Wenqiang Liu Selected Research
Wenqiang Liu Research Topics
Disease
13
Neoplasms (Cancer)
11/2023 - 01/2021
12
Infections
03/2024 - 01/2020
4
Neoplasm Metastasis (Metastasis)
01/2023 - 11/2017
4
Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2023
4
Diarrhea
02/2021 - 12/2019
3
Inflammation (Inflammations)
11/2024 - 01/2015
3
Body Weight (Weight, Body)
09/2022 - 01/2019
2
Viremia
03/2024 - 09/2022
2
Diabetes Mellitus
05/2023 - 01/2023
2
Cognitive Dysfunction
05/2023 - 01/2023
2
Thrombosis (Thrombus)
01/2023 - 01/2023
2
Osteosarcoma (Osteogenic Sarcoma)
01/2023 - 11/2021
2
Diabetic Retinopathy (Retinopathy, Diabetic)
01/2023 - 12/2022
2
Carcinoma (Carcinomatosis)
01/2023 - 01/2023
2
Influenza in Birds (Avian Flu)
12/2022 - 04/2020
2
Macular Degeneration (Age-Related Maculopathy)
01/2022 - 01/2020
2
Choroidal Neovascularization
01/2022 - 10/2020
1
Asthma (Bronchial Asthma)
11/2024
1
Allergic Rhinitis
11/2024
1
COVID-19
03/2024
1
Virus Diseases (Viral Diseases)
03/2024
1
Ischemic Stroke
02/2024
1
Rheumatoid Arthritis
12/2023
1
Breast Neoplasms (Breast Cancer)
08/2023
1
hypoglycemic encephalopathy
05/2023
1
Carcinogenesis
01/2023
1
Ganglion Cysts (Ganglion)
01/2023
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2023
1
Kidney Neoplasms (Kidney Cancer)
01/2023
1
Lung Neoplasms (Lung Cancer)
01/2023
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022
1
Glucose Intolerance
01/2022
1
Melanoma (Melanoma, Malignant)
01/2022
1
Metabolic Diseases (Metabolic Disease)
01/2022
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2022
Drug/Important Bio-Agent (IBA)
8
Proteins (Proteins, Gene)
FDA Link
01/2023 - 01/2013
4
Cytokines
IBA
11/2024 - 01/2021
4
Vaccines
IBA
03/2024 - 04/2010
4
Polysaccharides (Glycans)
IBA
02/2021 - 12/2019
3
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2023
3
Biomarkers (Surrogate Marker)
IBA
01/2023 - 12/2015
3
Hydrogels
IBA
10/2020 - 01/2019
2
Antiviral Agents (Antivirals)
IBA
03/2024 - 01/2020
2
Antioxidants
IBA
03/2024 - 01/2023
2
6-methyladenine
IBA
02/2024 - 12/2023
2
Interleukin-22 (IL-22)
IBA
05/2023 - 01/2023
2
Caspase 3 (Caspase-3)
IBA
05/2023 - 01/2023
2
Melatonin
IBA
01/2023 - 01/2022
2
Caspase 9
IBA
01/2023 - 01/2022
2
Glucose (Dextrose)
FDA Link
Generic
01/2023 - 01/2022
2
Eosine Yellowish-(YS) (Eosin)
IBA
01/2023 - 12/2022
2
rhodioloside
IBA
01/2023 - 01/2023
2
Retinaldehyde (Retinal)
IBA
12/2022 - 01/2020
2
Vascular Endothelial Growth Factors
IBA
01/2022 - 01/2019
2
Ubiquitin
IBA
11/2021 - 04/2020
1
Monoclonal Antibodies
IBA
11/2024
1
Therapeutic Uses
IBA
11/2024
1
Diltiazem (Cardizem)
FDA Link
Generic
03/2024
1
Amino Acids
FDA Link
03/2024
1
Enzymes
IBA
03/2024
1
Phospholipids (Phosphatides)
FDA Link
Generic
03/2024
1
Heme Oxygenase-1
IBA
03/2024
1
pseudorabies virus glycoprotein D
IBA
09/2023
1
Nanovaccines
IBA
09/2023
1
Estrogen Receptors
IBA
08/2023
1
Estrogens (Estrogen)
FDA Link
08/2023
1
Cyclin-Dependent Kinase 4
IBA
08/2023
1
Carrier Proteins (Binding Protein)
IBA
05/2023
1
Nerve Growth Factors (Neurotrophins)
IBA
05/2023
1
Interleukins
IBA
05/2023
1
dicarboxydine (DCD)
IBA
01/2023
1
Neutralizing Antibodies
IBA
01/2023
1
Early Growth Response Protein 2
IBA
01/2023
1
Dynamin II
IBA
01/2023
1
Hematoxylin (Haematoxylon)
IBA
01/2023
1
Clathrin Heavy Chains
IBA
01/2023
1
Proteome
IBA
01/2023
1
N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazide
IBA
01/2023
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2023
1
regorafenib
IBA
01/2023
1
Chloroquine (Aralen)
FDA Link
Generic
01/2023
1
Streptozocin (Streptozotocin)
FDA Link
01/2023
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2023
1
Sorafenib (BAY 43-9006)
FDA Link
01/2023
1
Ammonium Chloride (Sal Ammoniac)
FDA Link
01/2023
1
Malondialdehyde (Propanedial)
IBA
01/2023
1
Chlorpromazine (Thorazine)
FDA Link
01/2023
1
asoxime chloride (H16)
IBA
12/2022
1
Fluorescein (Funduscein)
FDA Link
Generic
12/2022
1
TNF Receptor-Associated Factor 6 (TRAF6)
IBA
12/2022
1
Anthraquinones
IBA
01/2022
1
6-chloro-2-(1-piperazinyl)pyrazine (CPP)
IBA
01/2022
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022
Therapy/Procedure
9
Therapeutics
08/2023 - 12/2019
2
Intraperitoneal Injections
01/2023 - 12/2022
2
Intravitreal Injections
01/2022 - 05/2019
2
Drug Therapy (Chemotherapy)
11/2017 - 12/2015
1
Nephrectomy
11/2023
1
Immunotherapy
01/2023
1
Intravenous Injections
01/2022